MARKET

SLGL

SLGL

SOL GEL TECHNOLG
NASDAQ

Real-time Quotes | Nasdaq Last Sale

7.97
-0.17
-2.09%
After Hours: 7.97 0 0.00% 16:00 10/18 EDT
OPEN
8.00
PREV CLOSE
8.14
HIGH
8.00
LOW
7.68
VOLUME
2.76K
TURNOVER
--
52 WEEK HIGH
11.36
52 WEEK LOW
5.41
MARKET CAP
162.49M
P/E (TTM)
-4.7438
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of SLGL and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

SLGL News

  • Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference
  • GlobeNewswire.4d ago
  • Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 40% Discount?
  • Simply Wall St..09/04 13:38
  • Sol-Gel Technologies Reports Second Quarter 2019 Financial Results and Corporate Update
  • GlobeNewswire.08/13 12:05
  • Sol-Gel Technologies Q2 EPS $0.29 Up From $(0.36) YoY
  • Benzinga.08/13 11:07

More

Industry

Biotechnology & Medical Research
-1.17%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About SLGL

Sol-Gel Technologies Ltd is a clinical-stage dermatology company. The Company is focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The Company’s offers a range of products twins, sirs-t, and vered. The Company is designed its proprietary, silica-based microencapsulation technology platform to enhance the tolerability and stability of topical drugs while maintaining their efficacy. Topical drugs often struggle to balance achieving both high efficacy and high tolerability. Its technology platform entraps active ingredients in an inert, inorganic silica shell, which creates an unnoticeable barrier between the active ingredient and the skin.
More

Webull offers Sol Gel Technologies Ltd (SLGL) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.